Sun Pharma slides 6% but Motilal Oswal recommends Buy: 3 reasons why Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider… 5 months ago
White House confirms April tariff exemptions for key sectors to continue: Copper, pharma, steel in focus The White House has extended key tariff exemptions under Executive Order 14257, shielding sectors like copper, steel, pharmaceuticals, and auto… 5 months ago
Trump tariff impact on Pharma: Breathing easy or trapped in crosshair ahead? Here’s how stocks are reacting Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what… 5 months agoJuly 31, 2025
Markets shrug off tariff shocker, Nifty hits 24,900 led by HUL, Jio Finance; Experts call it Trump ‘posturing’, share key advice Markets today at open, July 31: Markets plunge after Trump’s 25% tariff on Indian imports; track key losers and gainers… 5 months ago
25% tariff bomb: India’s electronics, pharma, textiles to be worst hit – Full list US President Donald Trump has announced a 25 per cent tariff and secondary sanctions on Indian goods starting August 1.… 5 months ago
Jubilant Pharmova Q1 profit slumps 78.66% on high base, revenue rises — What is the company betting on for future growth? Jubilant Pharmova reported a 78.66 per cent decline in Q1 profit due to a high base effect, even as revenue… 5 months ago
Upcoming earnings: From ITC, IndusInd Bank to BEL, Swiggy, more than 50 companies set to announce Q1 results this week As Q1FY26 earnings season heats up, Swiggy, Mahindra & Mahindra, ITC, Tata Power, Sun Pharma, UPL, and Maruti Suzuki are… 5 months agoJuly 28, 2025
Can stem cell therapies cure chronic diseases? Dr Gaurav Kharya on future of personalised medicines Dr Gaurav Kharya of Indraprastha Apollo Hospitals explains how stem cell therapies could potentially cure severe Type 1 diabetes. Explore… 5 months agoJuly 26, 2025
Cipla Q1FY26: Net profit rises 10% to Rs 1,298 crore Cipla reports 10 per cent rise in net profit to Rs 1,298 crore for Q1FY26 with India business crossing Rs… 5 months agoJuly 25, 2025
Pharma and MedTech units expect faster approvals, lower regulatory hurdles While UK tariffs on Indian drugs are already zero, the India-UK Free Trade Agreement is set to boost pharmaceutical and… 5 months ago
Trump holds Mercedes, BMW ‘hostage,’ warns potential European car sale ban in US if drug companies don’t… In an attempt to pull down drug prices for Americans. Donald Trump played the trade card on Tuesday, issuing a… 5 months ago
Pharma firms flag export risks from new compliance rules Even though the Pharmexcil doesn’t expect delay in the certification timelines, Joshi said that problem is with the transition period. 5 months agoJuly 12, 2025
Big news: AbbVie inks $700 million pact with Glenmark arm to develop and sell new cancer drug AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising trispecific T-cell… 5 months agoJuly 11, 2025
Lupin inks $50 million licensing deal with Zentiva for global biosimilar rollout Lupin has signed a $50 million licensing deal with Zentiva for the global commercialization of its biosimilar Certolizumab Pegol, targeting… 5 months agoJuly 9, 2025
Nectar Lifesciences sells core API and formulation business for Rs 1290 crore; stock crashes 20% Nectar Lifesciences’ API and formulation business generated 98.33 percent of the company’s total revenue/ income in the fiscal year 2025.… 5 months agoJuly 8, 2025
Sun Pharma steps up USFDA compliance drive: What’s changing at Halol, Mohali and Dadra? Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra. 5 months ago
Demerger announcement: Apollo Hospitals to list digital & pharmacy biz in 18-21 months Apollo Hospitals plans to spin off and list its digital and pharmacy businesses within 18–21 months, aiming to unlock value… 6 months agoJuly 1, 2025
Lupin gets US FDA nod for constipation drug Prucalopride tablets Lupin has received USFDA approval for its ANDA for Prucalopride Tablets, used to treat Chronic Idiopathic Constipation in adults. 6 months agoJune 25, 2025
Market Watchlist: Will earnings spark the breakout everyone’s waiting for? HDFC Bank, Tata Steel, Bajaj Finance among 9 stocks to watch
